Objectives: The primary objective was to investigate the mediating effects of diabetes management in the relationship between diabetes symptoms and generic health-related quality of life Abbreviations: AYA, adolescent and young adult; FDA, Food and Drug Administration; HbA1c, hemoglobin A1c (glycated hemoglobin); HRQOL, health-related quality of life; PedsQL, pediatric quality of life inventory; PRO, patient-reported outcome
| INTRODUCTION
The worldwide prevalence of type 1 diabetes is increasing in children, adolescents, and young adults.
1,2 Diabetes self-management is a crucial component of overall diabetes care, and represents a particular challenge during the adolescent and young adult (AYA) developmental period when competing demands may undermine successful disease control. 3 As AYA with type 1 diabetes assume greater responsibility for their health and well-being between childhood and emerging adulthood, they must also navigate the transition from pediatric to adult healthcare providers and settings. 4 These factors in combination may undermine the achievement of adequate diabetes management, and may be associated with less than optimal glycemic control and impaired overall health-related quality of life (HRQOL).
Patient-reported outcomes (PROs), including HRQOL and symptom-specific measurement instruments, 5 have assumed a greater role in determining the impact of pediatric diseases and treatments from the perspective of pediatric patients. 6 Particularly with the advent of the Food and Drug Administration (FDA) guidelines regarding PROs, 7 there has been a significantly increased emphasis on the integration of PROs with clinical and biological data in the evaluation of treatment efficacy for chronic health conditions.
Generic (general or non-disease-specific) HRQOL measures provide a common metric on which to compare interventions both within and across patient groups. 8 Generic HRQOL is a multidimensional construct, consisting at the minimum of the physical, psychological (including emotional and cognitive), and social health dimensions delineated by the World Health Organization. 7, 9 While generic HRQOL measurement instruments enable comparisons across patient populations and facilitate benchmarking with healthy population norms, diabetes-specific measurement instruments are essential to understanding symptoms and problems most relevant for patients with diabetes. 10 Further, based on the conceptualization of diseasespecific symptoms and problems as causal indicators of generic HRQOL, 11 it would be expected that diabetes-specific symptoms and problems would be significant predictors of impaired generic HRQOL.
Recently, we described the item development and 10-site national field test study for the PedsQL 3.2 Diabetes Module. [12] [13] [14] The PedsQL 3. . If more than 50% of the items in the scale are missing, the summary score is not computed. 21 Although there are other strategies for imputing missing values, this computation is consistent with previous PedsQL peer-reviewed publications as well as other wellestablished HRQOL measures. 6 For the current study, the percentage of missing item responses was 0.005% and 0.002% for the diabetes symptoms summary score and diabetes management summary score, respectively.
| PedsQL 4.0 generic core scales
The 23-item PedsQL 4.0 generic core scales encompass: physical functioning (eight items), emotional functioning (five items), social functioning (five items), and school functioning (five items). [22] [23] [24] To create the total scale score, the mean is computed as the sum of the items divided by the number of items answered in the physical, emotional, social, and school functioning scales. The total scale score measures overall generic HRQOL. 22 Higher scores indicate better HRQOL.
| PedsQL family information form
Participants completed the PedsQL Family Information Form which contains demographic information including age, gender, and race/ ethnicity. 22 
| Hemoglobin A1c
Hemoglobin A1c (HbA1c) 
| Body mass index
Body mass index (BMI) values were calculated from height and weight measures at each data collection site following the Centers for Disease Control and Prevention guidelines. 25 
| Statistical analysis
Pearson product-moment correlation analyses were conducted to test the bivariate associations between the diabetes symptoms summary score, diabetes management summary score, and the generic core scales total scale score. Bivariate correlation effect sizes are designated as small (0.10), medium (0.30), and large (0.50) in magnitude. 26 Predictive analytics models utilizing hierarchical multiple regression analyses were conducted to statistically predict the generic core scales total scale score by the diabetes symptoms summary score and diabetes management summary score after controlling for relevant demographic and clinical variables. 27 Hierarchical multiple regression analyses tested the change in the variance accounted for by the diabetes symptoms summary score (R 2 change). In each hierarchical multiple regression analysis predicting the generic core scales total scale score, gender (coded male = 1, female = 2) was entered in Step 1 as a demographic covariate and HbA1c and BMI were entered in Step 2 as clinical covariates. These covariates were included in the multivariate analyses since they were significantly correlated with the generic core scales total scale score in bivariate analyses. Only covariates significantly associated with the dependent variable at the bivariate level of analysis were included in the multivariate analyses. Hierarchical multiple regression analysis is a statistical approach that isolates the effects of a predictor variable on a criterion variable by controlling for the influence of covariates. 27 Mediator variables are hypothesized to account in part or fully for the relationship between a predictor variable and an outcome vari- Additionally, an exploratory factor analysis of the diabetes management summary score was conducted in order to determine whether the 18 items might be further grouped into item clusters or "facets". 31 A principal component factor analysis with promax rotation of the 18 items was conducted. Based on recommendations from the measurement literature, we included items with a factor loading of 0.40 or greater. 32 Cronbach's coefficient alpha was utilized to determine internal consistency reliability. 33 Internal consistency reliabilities of 0.70 or greater are recommended for comparing patient groups, while an internal consistency reliability criterion of 0.90 is recommended for analyzing individual patient scores. 34 Based on a conceptual model previously tested in pediatric inflammatory bowel disease, 19, 20 we also tested a more complex serial multiple mediator model 35 were conducted using the PROCESS macro for SPSS (processmacro.
org) as described in Hayes. 36 3 | RESULTS 
| Demographic and clinical characteristics

| Exploratory factor analysis
As shown in Table A1 , the 18 diabetes management items may be further delineated into the latent constructs labeled "perceived treatment adherence barriers," "procedural pain," "social embarrassment,"
"diabetes worry," and "health communication." Since the two health communication items loaded on Factor 3 with three items from the original a priori "Treatment Adherence Scale," an additional principal components factor analysis with promax rotation of the seven items comprising the "perceived treatment adherence barriers" latent variable was conducted. A single unidimensional factor emerged for these seven items (column 6 in Table A1 ). Controlling for the significant univariate covariates (HbA1c, BMI, and gender), diabetes symptoms significantly predicted HRQOL (β = .65, P < 0.001) and diabetes management (β = .54, P < 0.001), achieving the first two criteria for mediation. Diabetes management predicted HRQOL (β = .38, P < 0.001) controlling for diabetes symptoms and the covariates, supporting the third criterion for mediation.
When diabetes symptoms and diabetes management were simultaneously entered into the multiple regression analysis predicting HRQOL, the percentage of variance accounted for by diabetes symptoms was attenuated in predicting HRQOL (R 2 = .38, P < 0.001 vs comes. 37 For instance, healthcare providers and patients can mutually identify a set of priorities to discuss at a visit, and in a non-judgmental manner, healthcare providers can suggest strategies for addressing these priorities in a collaborative way. 38 The finding from the serial multiple mediator model that social embarrassment predicted perceived treatment adherence barriers is consistent with the literature in which individuals with diabetes report social stigma associated with their diabetes and diabetes treatment, which may undermine their attempts to treat their diabetes in social, school, or work environments. 39 Interventions to encourage AYA with type 1 diabetes to share their health experiences with their healthy peers may be a useful focus for future research. 40 This may include an openness about their diabetes diagnosis, symptoms and management with their classmates in the school setting. 41 Finally, perceived treatment adherence barriers may be targeted directly for self-management strategies designed to improve overall HRQOL in AYA with type 1 diabetes who are experiencing diabetes symptoms. 42 The present study has several strengths, including the relatively Hypothesized latent variables: Factor 1 = social embarrassment; Factors 2 and 3 = perceived treatment adherence barriers, except two items measuring health communication for Factor 3; Factor 4 = diabetes worry; Factor 5 = procedural pain.
